COMMUNIQUÉS West-GlobeNewswire

Benitec Biopharma Announces Updated Investor Webcast Information

14/10/2024 - 12:00

-Management plans to host an investor webcast on October 14 th at 8:30 am EDT to provide an update for the BB-301 Phase 1b/2a Clinical Study, details below- -The webcast access information has been revised from the [...]

Ardena élargit sa présence aux États-Unis avec l’acquisition d’une unité de production pharmaceutique du réseau Catalent

14/10/2024 - 12:00

Gand, Belgique, 14 oct. 2024 (GLOBE NEWSWIRE) -- Ardena, un sous-traitant pharmaceutique (ou CDMO pour Contract Development and Manufacturing Organisation) spécialisé dans le développement de nouveaux traitements [...]

Ardena Signs Agreement to Expand US Footprint with the Acquisition of Advanced Drug Product Manufacturing Facility from Catalent

14/10/2024 - 12:00

Ghent, Belgium, Oct. 14, 2024 (GLOBE NEWSWIRE) -- Ardena, a specialist pharmaceutical Contract Development and Manufacturing Organisation (CDMO) with GMP facilities in Belgium, Spain, the Netherlands and Sweden, today [...]

Orion’s collaboration partner Bayer submits application for third indication of darolutamide in the EU

14/10/2024 - 10:00

ORION CORPORATION INVESTOR NEWS 14 OCTOBER 2024 at 11.00 EEST Orion’s collaboration partner Bayer submits application for third indication of darolutamide in the EU Orion’s collaboration partner Bayer today announced [...]

Inventiva announces Filing of 2024 Half-Year Report – Conditions for Accessing or Consulting the Report

14/10/2024 - 08:35

Daix (France), Long Island City (New York, United States), October 14, 2024 – Inventiva (Euronext Paris and Nasdaq: IVA) (“ Inventiva ” or the “ Company ”), a clinical-stage biopharmaceutical company focused on the [...]

Inventiva publie son Rapport Financier Semestriel 2024 – Modalités de mise à disposition ou de consultation

14/10/2024 - 08:35

Daix (France), Long Island City (New York, États-Unis), le 14 octobre 2024 – Inventiva (Euronext Paris et Nasdaq: IVA) (« Inventiva » ou la « Société »), société biopharmaceutique spécialisée dans le développement [...]

Inventiva announces financing of up to €348 million to advance the NATiV3 Phase 3 MASH study

14/10/2024 - 08:30

Inventiva secures €94.1 million of a multi-tranche equity financing of up to €348 million, subject to satisfaction of specified conditions, from both new and existing investors, and up to $30 million in milestone [...]

Inventiva annonce un financement allant jusqu’à 348 millions d'euros afin d’avancer l’étude NATiV3 de Phase 3 dans la MASH

14/10/2024 - 08:30

► Inventiva obtient 94,1 millions d’euros dans le cadre d’un financement en plusieurs tranches d'un montant maximum de 348 millions d'euros, sous réserve de la réalisation de certaines conditions, avec la participation [...]

Nicox and Soleus Sign $16.5 million Royalty and Equity Financing

14/10/2024 - 07:30

Press Release Nicox and Soleus Sign $16.5 million Royalty and Equity Financing Gross proceeds of $15 million (€13.7 million) for the sale of Nicox’s net share of the VYZULTA royalty to Soleus Soleus investing $1.5 [...]

Nicox et Soleus signent un accord de financement de 16,5 millions de dollars combinant la vente de redevances et un financement en fonds propres

14/10/2024 - 07:30

Communiqué de presse Nicox et Soleus signent un accord de financement de 16,5 millions de dollars combinant la vente de redevances et un financement en fonds propres Produit brut de 15 millions de dollars (13,7 millions [...]

Majority of children with spinal muscular atrophy (SMA) treated with Roche’s Evrysdi are able to sit, stand and walk independently, two-year data demonstrate

14/10/2024 - 07:00

Positive data confirm Evrysdi efficacy and safety in children first treated pre-symptomatically before six weeks of age, with most achieving motor milestones similar to children without SMA All children were able to [...]

Cookie Diet announces the launch of new Four-Week Program

14/10/2024 - 01:20

Australia’s most convenient diet revealed: These famous weight-loss cookies make it easy to shred kilos AND there’s a money-back guarantee. SYDNEY, Australia, Oct. 14, 2024 (GLOBE NEWSWIRE) -- Dr Siegal’s famous Cookie [...]

Benitec Biopharma Reports Positive Data from Two Subjects Treated with Low-Dose BB-301 in Phase 1b/2a Study Presented at 29th Annual Congress of the World Muscle Society

12/10/2024 - 12:30

-Subject 1 and Subject 2 experienced durable, clinically meaningful improvements in swallowing at 9-months and 6-months post-BB-301 treatment, respectively, with Subject 2 achieving a Sydney Swallow Questionnaire Score [...]

MANGOCEUTICALS, INC. ANNOUNCES 1-FOR 15 REVERSE STOCK SPLIT AS PART OF NASDAQ COMPLIANCE PLAN

11/10/2024 - 23:15

DALLAS, TX, Oct. 11, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (“ MangoRx ” or the “ Company ”), a company focused on developing, marketing, and selling a variety of men’s health and wellness products [...]

Quest PharmaTech Announces Results from AGM

11/10/2024 - 23:00

EDMONTON, Alberta, Oct. 11, 2024 (GLOBE NEWSWIRE) -- Quest PharmaTech Inc. (TSX-V:QPT) (“Quest” or the “Company”) today announced the results of its October 8, 2024 annual general meeting of shareholders. The Company [...]

Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

11/10/2024 - 22:30

CAMBRIDGE, Mass., Oct. 11, 2024 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc. ® (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with [...]

Conavi Medical Corp. (formerly “Titan Medical Inc.”) Completes Business Combination

11/10/2024 - 22:30

TORONTO, Oct. 11, 2024 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (formerly, “ Titan Medical Inc. ”) (“the “ Resulting Issuer ” or the “ Corporation ”) (TSX: TMD; OTC: TMDIF) is pleased to announce the completion of the [...]

Voting Rights and Shares Capital of the Company

11/10/2024 - 22:15

In accordance with Articles L.233-8 II of the French Commercial Code and 223-16 of the General Regulation of the French Financial Markets Authority (Autorité des Marchés Financiers) PARIS, Oct. 11, 2024 (GLOBE NEWSWIRE [...]

Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social

11/10/2024 - 22:15

Conformément aux articles L.233-8 II du Code de commerce et 223-16 du Règlement Général de l’Autorité des Marchés Financiers PARIS, 11 oct. 2024 (GLOBE NEWSWIRE) -- Paris, France, le 11 octobre 2024 Place de cotation : [...]